vinblastine - CISMeF

Preferred Label : vinblastine;

MeSH definition : Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.);

MeSH synonym : vincaleukoblastine;

CISMeF synonym : faulding brand of vinblastine sulfate; gry brand of vinblastine sulfate; EG labo brand of vinblastine sulfate; lilly brand of vinblastine sulfate; hexal brand of vinblastine sulfate; cell pharm brand of vinblastine sulfate; lemery brand of vinblastine sulfate;

MeSH hyponym : vinblastin hexal; lemblastine; Vinblastinsulfat-Gry; velban; gastrozepin brand of vinblastine sulfate; cellblastin; Vinblastine Sulfate; Vinblastina Lilly; Velbe; Sulfate, Vinblastine;

MeSH Related Number : 865-21-4 (Vinblastine); vinblastine sulfate; N00W22YO2B;

Registry Number MeSH : 865-21-4;

Related CAS MeSH : N00W22YO2B (Vinblastine sulfate);

MeSH annotation : /biosyn permitted if by plant;

Wikipedia link : https://en.wikipedia.org/wiki/Vinblastine;

Codes EINECS : 212-734-0;

Is substance : O;

UNII : 5V9KLZ54CY;

InChIKey : JXLYSJRDGCGARV-CFWMRBGOSA-N;

Details

Origin ID

D014747;

UMLS CUI

C0042670;

ATC code(s)
- vinblastine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- vinblastine [Substance BNPC]
Pharmacological action(s)
- antineoplastic agents, phytogenic [MeSH Descriptor]
- tubulin modulators [MeSH Descriptor]
Record concept(s)
- Vinblastine Sulfate [MeSH concept]
- Vinblastinsulfat-Gry [MeSH concept]
- cellblastin [MeSH concept]
- lemblastine [MeSH concept]
- velban [MeSH concept]
- vinblastin hexal [MeSH concept]
- vinblastine [MeSH concept]
Related MeSH Supplementary Concept(s)
- 11'-iodovinorelbine [MeSH Supplementary Concept]
- 12'-iodovinblastine [MeSH Supplementary Concept]
- 16-O-acetylvindoline [MeSH Supplementary Concept]
- 16-demethoxyvindoline [MeSH Supplementary Concept]
- 16a'-homo-vinblastine [MeSH Supplementary Concept]
- 17-(((4-methyl-2-oxo-2H-benzopyran-7-yl)amino)-1,4-dioxobutyl)vinblastine [MeSH Supplementary Concept]
- 17-desacetoxyvinblastine N-oxide [MeSH Supplementary Concept]
- 20'-deoxyvinblastine N-oxide [MeSH Supplementary Concept]
- 3',4'-anhydrovinblastine [MeSH Supplementary Concept]
- 3,4,22-3-demethoxycarbonyl-3-hydroxylmethyl-4-deacetylvindoline 3,4-thionocarbonate [MeSH Supplementary Concept]
- 4'-deoxyvinblastine [MeSH Supplementary Concept]
- 4-O-(acetyl-hydroxyprolyl-seryl-seryl-cyclohexylglycyl-glutaminyl-seryl-seryl-prolyl)-desacetylvinblastine [MeSH Supplementary Concept]
- 4-O-deacetyl vinorelbine [MeSH Supplementary Concept]
- 4-O-deacetylvinblastine-3-oic acid [MeSH Supplementary Concept]
- 4-O-deacetylvinflunine [MeSH Supplementary Concept]
- 4-desacetylvinblastine [MeSH Supplementary Concept]
- 4-desacetylvinblastine 3-carboxyhydrazide monoclonal antibody conjugates [MeSH Supplementary Concept]
- 4-desacetylvinblastine hydrazide [MeSH Supplementary Concept]
- 4-desacetylvinblastine hydrazide-monoclonal antibody KS1-4 conjugate [MeSH Supplementary Concept]
- 4-desacetylvinblastine-monoclonal antibody KS1-4 conjugate [MeSH Supplementary Concept]
- 5a'-homo-vinblastine [MeSH Supplementary Concept]
- A-TRIPLE-V protocol [MeSH Supplementary Concept]
- AB-triple V protocol [MeSH Supplementary Concept]
- ABV-ADV protocol [MeSH Supplementary Concept]
- ABVD protocol [MeSH Supplementary Concept]
- ABVDP protocol [MeSH Supplementary Concept]
- ABVG protocol [MeSH Supplementary Concept]
- ACV protocol [MeSH Supplementary Concept]
- ALB 109564a [MeSH Supplementary Concept]
- AVM protocol [MeSH Supplementary Concept]
- AVTMF protocol [MeSH Supplementary Concept]
- AVV protocol [MeSH Supplementary Concept]
- B-CAVe protocol [MeSH Supplementary Concept]
- B-triple-V protocol [MeSH Supplementary Concept]
- BCMV protocol [MeSH Supplementary Concept]
- BOVAPEC protocol [MeSH Supplementary Concept]
- BVCPP protocol [MeSH Supplementary Concept]
- BVP protocol [MeSH Supplementary Concept]
- CBVD protocol [MeSH Supplementary Concept]
- CCNU-VP protocol [MeSH Supplementary Concept]
- CCVPP protocol [MeSH Supplementary Concept]
- CGV protocol [MeSH Supplementary Concept]
- CHIVPP protocol [MeSH Supplementary Concept]
- CISCA(II)-VB(IV) protocol [MeSH Supplementary Concept]
- COPP-ABVD protocol [MeSH Supplementary Concept]
- CVPP I protocol [MeSH Supplementary Concept]
- CVPP protocol [MeSH Supplementary Concept]
- CVPP regimen [MeSH Supplementary Concept]
- CVPPABO protocol [MeSH Supplementary Concept]
- Carbo-MVE protocol [MeSH Supplementary Concept]
- ChlVPP protocol [MeSH Supplementary Concept]
- ChlVPP-EVA regimen [MeSH Supplementary Concept]
- DMV protocol [MeSH Supplementary Concept]
- EBV protocol [MeSH Supplementary Concept]
- EBVD protocol [MeSH Supplementary Concept]
- EBVP protocol [MeSH Supplementary Concept]
- EC0905 [MeSH Supplementary Concept]
- EMV protocol [MeSH Supplementary Concept]
- EV protocol 1 [MeSH Supplementary Concept]
- EVA regimen [MeSH Supplementary Concept]
- EVAC-G-CSF protocol [MeSH Supplementary Concept]
- EVAP protocol [MeSH Supplementary Concept]
- EVAP regimen [MeSH Supplementary Concept]
- FAC-MV protocol [MeSH Supplementary Concept]
- FAN regimen [MeSH Supplementary Concept]
- FEN protocol [MeSH Supplementary Concept]
- FMN regimen [MeSH Supplementary Concept]
- FUVA protocol [MeSH Supplementary Concept]
- FVP protocol [MeSH Supplementary Concept]
- GV protocol [MeSH Supplementary Concept]
- HM 91 protocol [MeSH Supplementary Concept]
- HMiVe protocol [MeSH Supplementary Concept]
- KAR 3 [MeSH Supplementary Concept]
- KAR 4 [MeSH Supplementary Concept]
- LMV protocol [MeSH Supplementary Concept]
- LY 266070 [MeSH Supplementary Concept]
- M-CAVI protocol [MeSH Supplementary Concept]
- M-VAC protocol [MeSH Supplementary Concept]
- M-VEC protocol [MeSH Supplementary Concept]
- MEC protocol 1 [MeSH Supplementary Concept]
- MINE regimen [MeSH Supplementary Concept]
- MOPP-ABV protocol [MeSH Supplementary Concept]
- MOPPEBVCAD protocol [MeSH Supplementary Concept]
- MV protocol [MeSH Supplementary Concept]
- MV2 protocol [MeSH Supplementary Concept]
- MVC protocol 2 [MeSH Supplementary Concept]
- MVC regimen [MeSH Supplementary Concept]
- MVMJ protocol [MeSH Supplementary Concept]
- MVP protocol 1 [MeSH Supplementary Concept]
- MVP protocol 2 [MeSH Supplementary Concept]
- MVPF protocol [MeSH Supplementary Concept]
- MVPP protocol [MeSH Supplementary Concept]
- MVVPP protocol [MeSH Supplementary Concept]
- NAPAVIN [MeSH Supplementary Concept]
- NIP regimen [MeSH Supplementary Concept]
- NOVP protocol [MeSH Supplementary Concept]
- NaPIM protocol [MeSH Supplementary Concept]
- P-VEBEC protocol [MeSH Supplementary Concept]
- PAVe protocol 1 [MeSH Supplementary Concept]
- PCAV protocol [MeSH Supplementary Concept]
- PIN protocol [MeSH Supplementary Concept]
- POMB-ACE-PAV regimen [MeSH Supplementary Concept]
- PVA protocol [MeSH Supplementary Concept]
- PVB protocol [MeSH Supplementary Concept]
- PVC protocol [MeSH Supplementary Concept]
- PVP protocol 4 [MeSH Supplementary Concept]
- PVeBV protocol [MeSH Supplementary Concept]
- R-14 regimen [MeSH Supplementary Concept]
- SUPERFAN regimen [MeSH Supplementary Concept]
- TAVE protocol [MeSH Supplementary Concept]
- TAVH protocol [MeSH Supplementary Concept]
- TBV protocol [MeSH Supplementary Concept]
- TNCF regimen [MeSH Supplementary Concept]
- TVTG protocol [MeSH Supplementary Concept]
- VAB II protocol [MeSH Supplementary Concept]
- VAB protocol [MeSH Supplementary Concept]
- VAB-6 regimen [MeSH Supplementary Concept]
- VAB-III protocol [MeSH Supplementary Concept]
- VAB-IV protocol [MeSH Supplementary Concept]
- VABCD protocol [MeSH Supplementary Concept]
- VAIP protocol [MeSH Supplementary Concept]
- VAU regimen [MeSH Supplementary Concept]
- VBA protocol [MeSH Supplementary Concept]
- VBCMF protocol [MeSH Supplementary Concept]
- VBM protocol 2 [MeSH Supplementary Concept]
- VBVP protocol [MeSH Supplementary Concept]
- VCMA protocol [MeSH Supplementary Concept]
- VDD protocol [MeSH Supplementary Concept]
- VECABOP protocol [MeSH Supplementary Concept]
- VEP combination [MeSH Supplementary Concept]
- VEPEMB protocol [MeSH Supplementary Concept]
- VFP protocol [MeSH Supplementary Concept]
- VIF protocol [MeSH Supplementary Concept]
- VIG protocol [MeSH Supplementary Concept]
- VIP-VB protocol [MeSH Supplementary Concept]
- VPC protocol [MeSH Supplementary Concept]
- VPCBAE protocol [MeSH Supplementary Concept]
- VTMF protocol [MeSH Supplementary Concept]
- VTMFAP protocol [MeSH Supplementary Concept]
- VTMFP protocol [MeSH Supplementary Concept]
- VbCFM protocol [MeSH Supplementary Concept]
- VeIP protocol [MeSH Supplementary Concept]
- ViFuP protocol [MeSH Supplementary Concept]
- bis(N-ethylidene vindesine)disulfide [MeSH Supplementary Concept]
- caN protocol [MeSH Supplementary Concept]
- catharanthamine [MeSH Supplementary Concept]
- catharinine [MeSH Supplementary Concept]
- deacetoxyvinzolidine [MeSH Supplementary Concept]
- desacetylnavelbine [MeSH Supplementary Concept]
- dimethylaminomethylene vinamidinium salt [MeSH Supplementary Concept]
- modified M-VAC protocol [MeSH Supplementary Concept]
- stanford V protocol [MeSH Supplementary Concept]
- vinblastine-4'-anthranilate [MeSH Supplementary Concept]
- vincathicine [MeSH Supplementary Concept]
- vindoline [MeSH Supplementary Concept]
- vindolinine [MeSH Supplementary Concept]
- vindorosine [MeSH Supplementary Concept]
- vinepidine [MeSH Supplementary Concept]
- vinflunine [MeSH Supplementary Concept]
- vinleucinol [MeSH Supplementary Concept]
- vintriptol [MeSH Supplementary Concept]
- vintriptol acid [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing vinblastine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing vinblastine (medicinal product) [SNOMED CT concept]
- Vinblastine [ICD-11 Extension code]
- Vinblastine [NCIt concept]
- Vinblastine (substance) [SNOMED CT concept]
- vinblastine [ATC Code]
- vinblastine [Substance BNPC]
- vinblastine [SNOMED Notion]
Validated automatic mappings to BTNT
- Vinblastine Sulfate [NCIt concept]
- Vinblastine sulfate [Substance BNPC]
- Vinblastine sulfate (substance) [SNOMED CT concept]
- vinblastine [ATC Code]
- vinblastine sulfate [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients